IM Cannabis Corp. Files 6-K Report

Ticker: IMCC · Form: 6-K · Filed: 2025-05-06T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer, sec-report

TL;DR

IM Cannabis Corp. filed a routine 6-K, confirming its status as a foreign private issuer and its ongoing SEC reporting.

AI Summary

IM Cannabis Corp. filed a Form 6-K on May 6, 2025, reporting its status as a foreign private issuer. The company, incorporated in Israel with its principal executive offices at Kibbutz Glil Yam, Central District, Israel, is subject to reporting requirements under the Securities Exchange Act of 1934. IM Cannabis Corp. is listed under the SIC code 2833 for Medicinal Chemicals & Botanical Products.

Why It Matters

This filing indicates ongoing reporting obligations for IM Cannabis Corp. as a foreign private issuer, providing transparency to investors regarding its regulatory compliance.

Risk Assessment

Risk Level: low — This is a standard regulatory filing for a foreign private issuer and does not contain new financial or operational information that would indicate increased risk.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have filed or will file with a stock exchange.

What is IM Cannabis Corp.'s SIC code?

IM Cannabis Corp.'s SIC code is 2833, which corresponds to Medicinal Chemicals & Botanical Products.

Where are IM Cannabis Corp.'s principal executive offices located?

IM Cannabis Corp.'s principal executive offices are located at Kibbutz Glil Yam, Central District, Israel, 4690500.

Does IM Cannabis Corp. file annual reports under Form 20-F or 40-F?

IM Cannabis Corp. indicates it files annual reports under Form 20-F.

What is the filing date of this Form 6-K?

This Form 6-K was filed as of May 6, 2025.

From the Filing

0001178913-25-001590.txt : 20250506 0001178913-25-001590.hdr.sgml : 20250506 20250506072810 ACCESSION NUMBER: 0001178913-25-001590 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250506 FILED AS OF DATE: 20250506 DATE AS OF CHANGE: 20250506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25915238 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533116.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of May 2025 .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒    Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       IM CANNABIS CORP.     (Registrant)         Date: May 6, 2025 By: /s/ Oren Shuster     Name: Oren Shuster     Title: Chief Executive Officer and Director   EXHIBIT INDEX   99.1 News Release dated May 6, 2025 EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15 th at 9:00am ET   TORONTO and GLIL YAM, Israel, May 6, 2025  -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the " Company ", " IMCannabis ", or " IMC "), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens.   The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here . All relevant information will be sent upon registration.   If you are unable t

View on Read The Filing